Number |
1060 |
Age(y) |
36.3 ± 4.4 |
Gravity |
0.48 ± 0.8 |
Parity |
0.16 ± 0.4 |
Miscarriage |
0.32 ± 0.6 |
BMI (kg/m2) |
21.6 ± 5.4 |
Type of infertility |
|
Uterine factor |
14.9% (158) |
Fallopian tube factor |
24.0% (255) |
Ovulation factor |
15.8% (164) |
PCOS |
6.1% (65) |
Cervical factor |
9.5% (101) |
Endometriosis |
14.8% (157) |
Male factor |
32.0% (339) |
unexplained |
29.8% (316) |
Life style |
|
Smoking |
2.3% (24) |
Alcohol |
3.1% (33) |
Exercise |
6.4% (68) |
Basal FSH (IU/mL) |
8.0 ± 3.1 |
Basal LH(IU/mL) |
5.7 ± 2.6 |
Basal E2 (pg/mL) |
43.5 ± 44.5 |
AMH (ng/L) |
3.12 ± 3.0 |
25(OH) vitamin D (ng/mL) |
14.5 ± 5.8 |
Serum Homocysteine level (μmol/L) |
8.6 ± 2.3 |
Previous No. of IVF/ICSI failure |
1.9 ± 1.5 |
Previous No. of ET failure |
0.6 ± 1.1 |
Total gonadotropin dose used (IU/L) |
1647.2 ± 619.8 |
Endometrial thickness on hCG day (mm) |
10.1 ± 2.8 |
E2 level on hCG day(pmol/L) |
2042.6 ± 1386.2 |
Fertilization |
|
IVF |
43.9% (465) |
ICSI |
42.7% (453) |
Split |
10.1% (107) |
Ovulation regimens |
|
GnRH-agonist long protocol |
1.0% (11) |
GnRH-agonist short protocol |
0.6% (7) |
GnRH-antagonist |
72.2% (765) |
Moderate stimulation |
8.5% (90) |
PPOS |
17.6% (187) |
Total number of oocytes retrieved |
7.82 ± 5.9 |
No. of M-II oocytes |
6.1 ± 4.8 |
MII rate |
81.2% |
Fertilization rate |
74.0% |
No. of high-quality blastocyst |
1.8 ± 2.3 |
High quality blastocyst rate |
35.8% |